SentreHEART, Inc. Email Format
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
SentreHEART, Inc. is a privately held medical device company based in Redwood City, California. It develops the LARIAT Suture Delivery Device, which enables remote placement of a pre-tied suture loop for soft tissue ligation and approximation, including left atrial appendage exclusion. Regulatory clearances in the United States, Europe, and Canada cover soft tissue ligation and approximation. The company sponsors the FDA-approved aMAZE Trial, a prospective, multi-center randomized study designed to assess whether combining LAA closure with pulmonary vein isolation improves outcomes for patients with persistent or longstanding persistent atrial fibrillation. This clinical evidence program reflects its focus within the cardiovascular device field.